ET
AXSM icon

Entropy Technologies’s Axsome Therapeutics AXSM Stock Holding History

Entropy Technologies’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
4,473
-5,698
-56% -$1.24M 0.04% 487
2026
Q1 		$1.72M Buy
10,171
+1,979
+24% +$342K 0.08% 318
2025
Q4 		$1.5M Buy
+8,192
New +$1.14M 0.08% 303

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Entropy Technologies's AXSM Position: Q2 2026 in Review

Entropy Technologies reduced its Axsome Therapeutics (AXSM) stake by 56% in Q2 2026, selling an estimated $1.24M and leaving 4,473 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #487.

Entropy Technologies first reported a position in AXSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.72M in Q1 2026. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Entropy Technologies held 4,473 shares of Axsome Therapeutics worth $1.09M as of Q2 2026.
  • Entropy Technologies sold 5,698 Axsome Therapeutics shares in Q2 2026, an estimated $1.24M.
  • Axsome Therapeutics made up 0.04% of Entropy Technologies's portfolio in Q2 2026, its #487 holding.
  • Entropy Technologies first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Entropy Technologies's Axsome Therapeutics position peaked at $1.72M in Q1 2026.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.